Ask an expert about chronic myeloid leukaemia (CML) 

We marked Blood Cancer Awareness Month (September) with a webchat on chronic myeloid leukaemia (CML). This is quite a rare type of cancer, with 750 new cases diagnosed in the UK each year.

Our expert was consultant haematologist Dr Andres Virchis. He is the clinical lead for CML at UCLH and runs a weekly clinic for patients with CML at University College Hospital Macmillan Cancer Centre. He manages patients in a variety of clinical situations and treats patients using all tyrosine kinase inhibitors (TKI) – the type of drugs that are typically used as anticancer drugs. UCLH is specialist centre for the treatment of blood cancers across north and east London and west Essex. We are also building a new facility which will make UCLH the largest specialist treatment centre for blood diseases in Europe.

The conversation focussed on living with CML and managing the condition from diagnosis to treatment.

Live Blog Web chat: Ask an expert about chronic myeloid leukaemia (CML)
 

 Useful links